Research Article
Patterns of Anthracycline-Based Chemotherapy-Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in Ethiopia: A Prospective Observational Study
Table 3
Relative dose intensity of Adriamycin, cyclophosphamide, and paclitaxel among breast cancer patients on AC and AC-T regimen at TASH, from January 1 to September 30, 2017 GC.
| |||||||||||||||||||||||||||||||||||||||||||||||||
A = Adriamycin; C = cyclophosphamide; Q3W = every three weeks; RDI = relative dose intensity; T = paclitaxel 44 (30.1%) of the patients had overall RDI < 85%. |